Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Tarbp2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of TARBP2 mRNA | CTD | PMID:17555576 | Tarbp2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Tarbp2 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Tarbp2 | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TARBP2 mRNA | CTD | PMID:32145629 | Tarbp2 | Rat | 17beta-estradiol 3-benzoate | increases methylation | EXP | | 6480464 | estradiol 3-benzoate results in increased methylation of TARBP2 promoter | CTD | PMID:27415467 | Tarbp2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Tarbp2 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of TARBP2 mRNA | CTD | PMID:30294300 | Tarbp2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TARBP2 mRNA | CTD | PMID:21570461 | Tarbp2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TARBP2 mRNA | CTD | PMID:32109520 | Tarbp2 | Rat | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of TARBP2 mRNA | CTD | PMID:21346803 | Tarbp2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of TARBP2 mRNA | CTD | PMID:21346803 | Tarbp2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of TARBP2 mRNA | CTD | PMID:18648102 | Tarbp2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2,6-dinitrotoluene affects the expression of TARBP2 mRNA | CTD | PMID:21346803 | Tarbp2 | Rat | aflatoxin B1 | increases methylation | ISO | TARBP2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TARBP2 gene | CTD | PMID:27153756 | Tarbp2 | Rat | atrazine | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of TARBP2 mRNA | CTD | PMID:22378314 | Tarbp2 | Rat | benzo[a]pyrene | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of TARBP2 mRNA | CTD | PMID:21715664 | Tarbp2 | Rat | benzo[a]pyrene | decreases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of TARBP2 mRNA | CTD | PMID:22228805 | Tarbp2 | Rat | benzo[a]pyrene | multiple interactions | ISO | Tarbp2 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TARBP2 mRNA] | CTD | PMID:22228805 | Tarbp2 | Rat | bisphenol A | increases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of TARBP2 mRNA | CTD | PMID:20678512 | Tarbp2 | Rat | bisphenol A | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of TARBP2 mRNA | CTD | PMID:33221593 | Tarbp2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TARBP2 mRNA | CTD | PMID:32145629|PMID:34947998 | Tarbp2 | Rat | bisphenol A | increases methylation | ISO | Tarbp2 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of TARBP2 promoter | CTD | PMID:27312807 | Tarbp2 | Rat | bisphenol A | affects methylation | EXP | | 6480464 | bisphenol A affects the methylation of TARBP2 promoter | CTD | PMID:27415467 | Tarbp2 | Rat | bisphenol A | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of TARBP2 mRNA | CTD | PMID:25181051 | Tarbp2 | Rat | bisphenol F | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | caffeine | affects phosphorylation | ISO | TARBP2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of TARBP2 protein | CTD | PMID:35688186 | Tarbp2 | Rat | cannabidiol | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of TARBP2 mRNA | CTD | PMID:27714895 | Tarbp2 | Rat | chlordecone | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Chlordecone results in increased expression of TARBP2 mRNA | CTD | PMID:29980752 | Tarbp2 | Rat | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of TARBP2 mRNA | CTD | PMID:20187946 | Tarbp2 | Rat | coumarin | increases phosphorylation | ISO | TARBP2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of TARBP2 protein | CTD | PMID:35688186 | Tarbp2 | Rat | dexamethasone | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | Dibutyl phosphate | affects expression | ISO | TARBP2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of TARBP2 mRNA | CTD | PMID:37042841 | Tarbp2 | Rat | dibutyl phthalate | decreases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of TARBP2 mRNA | CTD | PMID:21266533 | Tarbp2 | Rat | diclofenac | multiple interactions | ISO | Tarbp2 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Tarbp2 | Rat | dioxygen | decreases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of TARBP2 mRNA | CTD | PMID:24205000 | Tarbp2 | Rat | diquat | decreases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Diquat results in decreased expression of TARBP2 protein | CTD | PMID:36851058 | Tarbp2 | Rat | doxorubicin | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TARBP2 mRNA | CTD | PMID:29803840 | Tarbp2 | Rat | elemental selenium | increases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Selenium results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | Tarbp2 | Rat | elemental selenium | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | Tarbp2 | Rat | FR900359 | decreases phosphorylation | ISO | TARBP2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of TARBP2 protein | CTD | PMID:37730182 | Tarbp2 | Rat | ibuprofen | multiple interactions | ISO | Tarbp2 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Tarbp2 | Rat | indometacin | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Tarbp2 | Rat | ivermectin | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TARBP2 protein | CTD | PMID:32959892 | Tarbp2 | Rat | Mesaconitine | increases expression | EXP | | 6480464 | mesaconitine results in increased expression of TARBP2 protein | CTD | PMID:37182599 | Tarbp2 | Rat | methamphetamine | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of TARBP2 mRNA | CTD | PMID:26307267 | Tarbp2 | Rat | methylseleninic acid | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of TARBP2 mRNA | CTD | PMID:18548127 | Tarbp2 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TARBP2 mRNA | CTD | PMID:25729387 | Tarbp2 | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of TARBP2 mRNA | CTD | PMID:25729387 | Tarbp2 | Rat | pirinixic acid | increases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TARBP2 mRNA | CTD | PMID:18301758 | Tarbp2 | Rat | rotenone | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of TARBP2 protein | CTD | PMID:39603559 | Tarbp2 | Rat | selenium atom | increases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Selenium results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | Tarbp2 | Rat | selenium atom | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | Tarbp2 | Rat | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite inhibits the reaction [AGO2 protein binds to TARBP2 protein] | CTD | PMID:30404558 | Tarbp2 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of TARBP2 mRNA | CTD | PMID:19281266 | Tarbp2 | Rat | thiram | decreases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Thiram results in decreased expression of TARBP2 mRNA | CTD | PMID:38568856 | Tarbp2 | Rat | titanium dioxide | decreases methylation | ISO | Tarbp2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of TARBP2 gene | CTD | PMID:35295148 | Tarbp2 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of TARBP2 mRNA | CTD | PMID:25729387 | Tarbp2 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TARBP2 mRNA | CTD | PMID:25729387 | Tarbp2 | Rat | triptonide | decreases expression | ISO | Tarbp2 (Mus musculus) | 6480464 | triptonide results in decreased expression of TARBP2 mRNA | CTD | PMID:33045310 | Tarbp2 | Rat | valproic acid | affects expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TARBP2 mRNA | CTD | PMID:25979313 | Tarbp2 | Rat | vitamin E | multiple interactions | ISO | TARBP2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | Tarbp2 | Rat | vitamin E | increases expression | ISO | TARBP2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of TARBP2 mRNA | CTD | PMID:19244175 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















